The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects
Open accessAbstract
Prophylactic vaccines for human papillomavirus (HPV) are being introduced in many countries for the prevention of cervical cancer, the second most important cause of cancer-related death in women globally. This is likely to have a significant impact on the future burden of cervical cancer, particularly where screening is non-existent or limited in scale. Previous research on the challenges of vaccinating girls with the HPV vaccine has focused on evidence from developed countries. We conducted a systematic search of the literature in order to describe the barriers and challenges to implementation of HPV vaccine in low- and middle-income countries. We identified literature published post-2006 to September 2012 from five major databases. We validated the findings of the literature review with evidence from qualitative key informant interviews. Three key barriers to HPV vaccine implementation were identified: sociocultural, health systems and political. A linked theme, the sustainability of HPV vaccines programmes in low- and middle-income countries, cuts across these three barriers. Delivering HPV vaccine successfully will require multiple barriers to be addressed. Earlier research in developed countries emphasised sociocultural issues as the most significant barriers for vaccine roll-out. Our evidence suggests that the range of challenges for poorer countries is significantly greater, not least the challenge of reaching girls for three doses in settings where school attendance is low and/or irregular. Financial and political barriers to HPV vaccine roll-out continue to be significant for many poorer countries. Several demonstration and pilot projects have achieved high rates of acceptability and coverage and lessons learned should be documented and shared.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study
Jaspers, L., Budiningsih, S., Wolterbeek, R., Henderson, F. C., & Peters, A. A. W. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.107 · Cited by 113
Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India
Madhivanan, P., Krupp, K., Yashodha, M. N., Marlow, L., Klausner, J. D., & Reingold, A. L. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.073 · Cited by 98
Jacob, M., Mawar, N., Menezes, L., Kaipilyawar, S., Gandhi, S., Khan, I., Patki, M., Bingham, A., LaMontagne, D. S., Bagul, R., et al. (2010) · The Open Vaccine Journal · doi:10.2174/1875035401003010096 · Cited by 29
Cited by
The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012
Shield, K. D., Ferlay, J., Jemal, A., Sankaranarayanan, R., Chaturvedi, A. K., Bray, F., & Soerjomataram, I. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21384 · Cited by 724
Global cancer patterns: causes and prevention
Vineis, P., & Wild, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62224-2 · Cited by 709
Changing global policy to deliver safe, equitable and affordable care for women's cancers
Ginsburg, O., Badwe, R., Boyle, P., Derricks, G., Dare, A., Evans, T., Eniu, A., Jimenez, J., Kutluk, T., Lopes, G., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31393-9 · Cited by 102
Xu, M., Choi, J., Capasso, A., & DiClemente, R. (2024) · Adolescent Health, Medicine and Therapeutics · doi:10.2147/ahmt.s394119 · Cited by 30
Stemming the wave of cervical cancer: Human papillomavirus vaccine introduction in India
Mehrotra, R., Hariprasad, R., Rajaraman, P., Mahajan, V., Grover, R., Kaur, P., & Swaminathan, S. (2018) · Journal of Global Oncology · doi:10.1200/jgo.17.00030 · Cited by 25
Metadata
- Authors
- Wigle, J., Coast, E., & Watson-Jones, D.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 31
- Issue
- 37
- Pages
- 3811-3817
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2145444171
- Cited by
- 192
- References
- 3
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects. https://app.cochat.ai/papers/10.1016/j.vaccine.2013.06.016
- The paper
- Wigle, J., Coast, E., & Watson-Jones, D. (2013). Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects. Vaccine. https://doi.org/10.1016/j.vaccine.2013.06.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.